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Glycolipid antigens recognized by αβ T cell receptors (TCRs) drive
the activation of invariant natural killer T (iNKT) cells, a special-
ized subset of innate T lymphocytes. Glycolipids with α-linked
anomeric carbohydrates have been identiﬁed as potent microbial
lipid antigens for iNKT cells, and their unusual α-anomeric linkage
has been thought to deﬁne a ‘foreign’ lipid antigen motif. Yet
mammals use endogenous lipids to select iNKT cells, and there
is compelling evidence for iNKT cell responses in various types
of sterile inﬂammation. The nature of endogenous or environ-
mental lipid antigens encountered by iNKT cells is not well de-
ﬁned. Here, we sought to identify lipid antigens in cow’s milk, a
prominent part of the human diet. We developed a method to
directly capture lipid antigens within CD1d-lipid-TCR complexes,
while excluding CD1d-bound to non-antigenic lipids, followed by
direct biochemical analysis of the lipid antigens trapped at the
TCR-CD1d interface. The speciﬁc antigens captured by this ‘TCR
trap’ method were identiﬁed as α-linked monohexosylceramides
by mass spectrometry fragmentation patterns that distinguished
α- from β-anomeric monohexosylceramides. These data provide
direct biochemical evidence for α-linked lipid antigens from a
common dietary source.
NKT | iNKT | Lipid antigen | CD1d
Introduction
Adaptive mammalian T lymphocytes are well known for their
use of combinatorial diversity to generate a broad repertoire of
antigen receptors, a process that evolved to recognize newly-
encountered peptide epitopes from pathogens. However, certain
subsets of human T cells, such as invariant natural killer T (iNKT)
cells, mucosal-associated invariant T (MAIT) cells, and germline-
encoded mycolyl-reactive (GEM) T cells reliably generate T cell
receptors (TCRs) that are conserved among genetically diverse
humans, and in some cases, across species (1). Recent data in-
dicate that T cells expressing such invariant TCRs comprise a
significant fraction of all human T cells, estimated in the range
of 10 to 20 percent (2). Further, these conserved T cell subsets
are not restricted by major histocompatibility (MHC)-encoded
antigen presenting molecules, but instead can recognize differ-
ent chemical classes of antigens presented by non-polymorphic
antigen presentingmolecules including CD1,MR1 orHLA-E (3).
One of these conserved T cell populations, iNKT cells, recog-
nizes specific glycolipids presented byCD1dmolecules. Following
activation, iNKT cells respond rapidly with vigorous cytokine
production that can profoundly shape immune responses (4).
Although a glycolipid antigen for iNKT cells was identified
from a marine sponge more than 20 years ago as part of a
chemical library screen (5), the origins and chemical identities of
physiologically-relevant antigens that drive selection and activa-
tion of iNKT cells remain controversial. Natural antigenic glycol-
ipids have been detected from various foreign sources, including
non-pathogenicα-proteobacteria (6-8), spirochetes (9), and other
microbes such as Streptococcus pneumoniae (10), and Bacteroides
fragilis (11, 12). These known microbial lipid antigens for iNKT
cells share a key biochemical feature, namely an α-anomeric link-
age of one hexose sugar to the lipid backbone. Mammals abun-
dantly produce β-linked hexosylceramides, glucosylceramide and
galactosylceramide, but were not previously thought to produce
α-linked hexosylceramides. Therefore, a major principle of anti-
gen recognition by iNKT cells has been that self-glycolipids are
β-linked and not strongly recognized, while pathogens produce
lipids that are recognized as foreign based on their α-anomeric
linkage (5). However, pathogen-derived lipids presumably do not
explain the TCR- and CD1d-dependent activation of iNKT cells
during positive selection in the thymus, or in settings such as viral
infection, cancer, or sterile inflammation (4). Endogenous lipids
have long been proposed to activate iNKT cells in these settings.
It is possible that the longstanding view that mammalian
monohexosylceramides are always β-linked is incorrect. Kain
and colleagues showed that antibodies raised against α-linked
glycosphingolipids could stain mammalian tissues (13). We re-
cently fractionated mammalian milk-derived lipids, finding that
antigenic substances were enriched in the hexosylceramide-
containing fraction, and that antigenicity was not abrogated
by β-specific glycosidases or chromatographic depletion of β-
Signiﬁcance
Invariant natural killer T (iNKT) cells are activated quickly and
play a key role in the control of many microbial infections
via their ability to rapidly secrete cytokines and chemokines
that enhance many immune responses. Microbial glycolipid
antigens that activate iNKT cells have been identiﬁed as α-
anomerically linked glycolipids. However, the nature of the en-
dogenous lipid antigens that are important contributors to the
biology of iNKT cells has been unclear. In this study, antigenic
lipids from cow’s milk were isolated using a T cell receptor trap
method, and their stereochemical structures were determined
to be hexosylceramides with α-linked hexose headgroups,
thus identifying dietary lipid antigens for iNKT cells.
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Submission PDFFig. 1. iNKT cell activation by milk hexosylceramides. (A) A cow’s milk
glucosylceramide-fraction was digested with recombinant lysosomal glucosi-
dase to reduce β-glucosylceramide. The remaining material detected at the
monohexosylceramide retention time was puriﬁed by preparative TLC and
further resolved to upper and lower fractions. (B) TLC fractions were tested
for activity by co-culture with the DN32 iNKT cell hybridoma and CD1d-
transfected RAW-264.7 cells. (C) CD1d monomers loaded with the indicated
lipids were assembled into tetramers that were used to stain BW58 cells
transfected with an iNKT cell TCR or with a diverse NKT cell TCR that does
not recognize α-galactosylceramide. Numbers indicate geometric mean ﬂu-
orescence values. Data are representative of two independent experiments
performed with separate starting material.
glucosylceramides (14). Both studies point to the possibility that
α-linked lipids are produced in mammalian tissues. However, if
they exist, they are likely scarce compounds and they have not
been isolated in sufficient yield to confirm α-anomeric structures
through direct biochemical analysis. Given the importance of the
‘α-linked self-lipid hypothesis’ to iNKT cell biology, we sought to
identify mammal-derived antigenic lipids.
Here, we used soluble iNKT TCR and soluble CD1d to
capture the subset of lipids from cow’s milk that form stable
TCR-lipid-CD1d complex through direct analysis of TCR-lipid-
CD1d complexes. Combining this TCR ‘trapping’ of CD1d-lipid
antigen complexes with nanoelectrospray ionization (ESI) mass
spectrometry (MS) and liquid chromatography-mass spectrome-
try (LC-MS), we could detect monohexosylceramides from cow’s
milk as lipid antigens. Using MS-based methods, we determined
that the captured lipid antigens were α-linked monohexosylce-
ramides. This study identifies the biochemical structures of nat-
ural cow’s milk-derived lipid antigens as α-anomeric hexosylce-
ramides, supporting the hypothesis that α-linked lipids are iNKT
cell antigens even in the absence of pathogens.
Results
Pre-purification of milk lipid antigens for iNKT cells. We pre-
viously showed that the glucosylceramide-containing fraction of
cow’s milk contains antigenic lipids for iNKT cells (14, 15). To
further purify and identify the milk-derived lipid antigens, we
digested a milk hexosylceramide lipid fraction with β-glucosidase
to destroy the β-linked glucosylceramides. Thin layer chromatog-
raphy (TLC) showed that this treatment markedly reduced the
total mass of glycolipids co-migrating with a glucosylceramide
Fig. 2. TCR trap assay. (A) Synthetic α-glucosylceramide was loaded in
recombinant CD1dmolecules, mixed with recombinant iNKT cell TCRs (2C12),
and run over a size-exclusion chromatography column. (B) Lipids were eluted
from the early fraction excluded from the column and analyzed by linear ion
trap MS. A dominant ion corresponding to the α-glucosylceramide standard
was recovered and few other ions were detected. (C) The activity-enriched
milk monohexosylceramide fraction was loaded in CD1d and treated as in
(Fig. 2A). (D) The early fraction, CD1d alone, or TCR alone, were resolved on
an SDS-PAGE gel and total proteins stained, yielding bands corresponding
to TCR, CD1d, and β2M. Data are representative of two independent exper-
iments performed with separate starting material.
standard, yet did not reduce the potency of iNKT cell activation
(Fig. 1A). This result could be explained if the starting material
was predominantly composed of non-antigenic β-linked glucosyl-
ceramides, and antigenic α-linked hexosylceramides were present
in milk that survived the enzyme treatment. To address this possi-
bility, we used a TLC separation method that resolved monohex-
osylceramide α- and β- anomers (15), yielding two bands. Only
the lower band, which co-migrated with an α-glucosylceramide
standard, stimulated an iNKT cell response (Fig. 1B), suggesting
that α-linked hexosylceramides could be present. However, this
interpretation is contrary to the prevailing view that mammalian
products contain only β-linked hexosylceramides. The lower band
that activated iNKT cells (Fig. 1A,B) which we refer to as the
“activity-enriched” fraction, represented a very small fraction of
totalmilk hexosylceramides, which provided an obstacle to formal
biochemical identification of the antigen. Thus, we considered
new approaches to antigen discovery.
Milk lipids mediate CD1d-TCR binding. Nearly all prior
approaches to antigen discovery, including that described above
(Fig. 1A), have relied on a correlation between two assays that
separately measure T cell activation and biochemical content.
The final antigen identification relies on the premise that the
most readily detectable molecules are also the T cell stimulants.
By definition, antigenic lipids ligate TCRs to antigen-presenting
molecules with higher affinity than non-antigenic lipids, so we
reasoned that a recombinant iNKTTCRwith relatively high affin-
ity for CD1d-α-galactosylceramide complexes, known as 2C12
(16), might selectively trap those CD1d complexes carrying milk-
derived antigens, while leaving behind CD1dmolecules that were
bound to non-antigenic lipids. Such a TCR trap approach was re-
cently used to identify CD1a autoantigens (17). We hypothesized
that this approach might be feasible for CD1d and milk-derived
antigens, since partially-enrichedmilk fractions couldmediate the
physical binding of CD1d tetramers to cells expressing an iNKT
cell Vα14Jα18 Vβ8.2Jβ2.1 TCR, but not to cells expressing a
sulfatide-reactive diverseNKT cell Vα1Jα26Vβ16Jβ2.1 TCR (18,
19). Staining of iNKT TCR-expressing cells with CD1d tetramers
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Fig. 3. Linear ion trap MS analysis of CD1-lipid-TCR complexes.. (A) Lipids extracted from the TCR trap assay fractions indicated Fig. 2C were analyzed by
linear ion trap MS. Prominent ions from the late fraction were identiﬁed as (B) phosphatidylcholine, (C) phosphatidylethanolamine, (D) sphingomyelin, and
(E) type 1 monohexosylceramide. (F) All major ions in the early fraction were an alkane series, and collision of 6 of the most abundant ions generated type
2 monohexosylceramide patterns. (G) Lipids were extracted from the early fraction, quantiﬁed, and co-cultured with the DN32 iNKT cell hybridoma and
CD1d-transfected RAW-264.7 cells. Experiments were performed on lipids extracted two independent TCR trap assays.
Fig. 4. HPLC-MS analysis with Q-Tof MS detection. Lipids extracted from TCR trap assay fractions were analyzed by Q-ToF HPLC-MS experiments to provide
high mass accuracy conﬁrmation of the structures deduced in Fig. 3, measure lipid binding to TCR and to measure retention time in comparison with standards.
HPLC tracings are shown for selected targeted ions based on predicted masses for the structures identiﬁed in Fig. 3. Experiments were performed on lipids
extracted two independent TCR trap assays.
loaded with activity-enriched milk lipids was stronger than stain-
ing with unloaded CD1d tetramers, but weaker than tetramers
generated with known potent lipid antigens α-galactosylceramide
and α-glucosylceramide (Fig. 1C). Thus, cow’s milk contained
compounds capable of mediating CD1d-TCR binding.
TCR Trap Assay. To develop a cell-free assay to detect lipid
antigens, we tested the TCR trap system by loading recombinant
soluble CD1d with synthetic α-glucosylceramide, and then mix-
ing this antigen-loaded CD1d with recombinant soluble iNKT
cell TCR monomers. The subset of CD1d proteins carrying α-
glucosylceramide was expected to bind TCR heterodimers lead-
ing to the formation of a higher molecular weight ternary com-
plex, which could be purified by size exclusion gel chromatogra-
phy. A mixture of α-glucosylceramide-treated CD1d and TCRs
showed a large early fraction that eluted prior to separate CD1d
and TCR monomers (Fig. 2A), consistent with a larger protein
complex. After eluting lipids from this fraction using a mixture
of chloroform and methanol, positive mode nanoelectrospray
MS identified a prominent ion at m/z 832.7, corresponding to α-
glucosylceramide ([M+Na], M=C48H91NO8), as well as its iso-
topes. The lack of other ions present above background levels
indicated that lipids from culture media or those potentially
carried by the outer surface of CD1d or TCRs did not substan-
tially confound the analysis (Fig. 2B). Thus, α-glucosylceramide
performed its expected role in ligating CD1d to TCR, and direct
analysis of CD1d-lipid-TCR complexes was sufficient to identify
the ligating molecule without interference by other substances
adherent to the lipid-protein complex.
Next, to identify unknown lipids, we used this TCR trap assay
with CD1dmolecules that had been loaded with activity-enriched
cow’s milk monohexosylceramides (Fig. 1A,B). A small but de-
tectable peak was observed in the early size exclusion fractions
and this showed no overlap with CD1d or TCR monomer frac-
tions (Fig. 2C). Coomassie staining of the early fraction revealed
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Fig. 5. Linear ion trap MS distinguishes α- from β-hexosylceramides. (A) Lipid standards were synthesized based on the structures of the type 2
monohexosylceramides and tested in co-culture with the DN32 iNKT cell hybridoma and CD1d-transfected RAW-264.7 cells. (B) MS-MS of sodiated adducts
demonstrated characteristic fragmentation patterns for α- and β-glucosylceramide synthetic standards when studied over a range of collision energy settings.
(C) Linear ion trapMS-MSwas performed on the cow’s milk unenriched, activity-enriched, and TCR trap early fraction lipids. Three experiments were performed
for (A) and (B). Experiments in (C) were performed on lipids extracted two independent TCR trap assays.
three proteinsmatching the apparentmolecular weights of CD1d,
β2m, and TCR with band similar intensity, consistent with 1:1:1
stoichiometry (Fig. 2D). The peak height of the protein trace
of the early eluting fraction made with milk lipids (Fig. 2C) was
substantially lower than that of the early fractionmadewith CD1d
carrying synthetic α-glucosylceramide (Fig. 2A), suggesting that
TCRs bound to a small fraction of the total pool of CD1d-lipid
complexes present. However, since this peak was observed at the
same elution time as the synthetic α-glucosylceramide standard-
loaded CD1d, it suggested that the milk lipid-derived ternary
complex carried a high-affinity antigen.
Nanoelectrospray analysis of all eluted milk lipids in the late
fraction containing CD1d and TCR monomers found numerous
ions, and the mass intervals among the most abundant ions were
diverse, suggesting the presence of structurally diverse lipids from
many classes (Fig. 3A, upper). In contrast, the early fraction,
which contained CD1d-TCR complexes, showed fewer eluted
ions (Fig. 3A, lower). The lower peak height from the size ex-
clusion tracing and the less complex MS profiles suggested that
the iNKT cell TCR selected small subset of CD1d-milk lipid
complexes from among all CD1d-lipid complexes present in the
starting material. In fact, nearly all nanoelectrospray MS signals
derived from the early-eluting CD1d-TCR complexes could be
accounted for by a single alkane series comprised of lipids of
m/z 710.7, apparent chain-length analogs (m/z 724.7, 738.7, 752.6,
794.7, 808.8, 822.8, 836.8), and the isotopes of these lipids.
TCR ligands identified using nanoelectrospray MS. Next we
identified the lipid ligands trapped-in or excluded-from CD1d-
TCR complexes using shotgun nanoelectrospray with multi-stage
ion trap MS. This method provides high sensitivity, broad detec-
tion, and structural information from collision-induced dissocia-
tion (CID), but offers relatively low mass accuracy. Considering
lipids eluted from the late fraction containing CD1d and TCR
monomers, CID-MS of selected ions at m/z 738.4, 753.5, and
808.5 identified phosphatidylethanolamine, sphingomyelin, and
phosphatidylcholine (Fig. 3B-D). In addition, fragments from the
ion atm/z 722.6 corresponded a hexosylceramide whose two fatty
acid chains had a combined lipid tail length of C34 with one un-
saturation (Fig. 3E). This ‘type 1’monohexosylceramide collision
pattern was characterized by a dehydration (loss of 18 mu, m/z
704.5), loss of a hexosyl unit (162 mu, m/z 560.5), and loss of
both fragments (loss of 180 mu,m/z 542.4). In contrast, ions from
early fraction containing CD1d-TCR complexes did not show
detectable signals for phosphatidylethanolamine, sphingomyelin,
or phosphatidylcholine. Instead, complexes in the early fraction
released matched expected masses of a ‘type 2’ hexosylceramide,
which unlike type 1 patterns, lacked a dehydration ion but did
show a loss of 162 mu. In fact, the abundant ions in the early
fraction were all accounted for by single alkane series corre-
sponding to an monohexosylceramide with an overall lipid length
ranging between C33 (m/z 710.7) and C42 (m/z 836.8). Separate
analysis of six members of this alkane series demonstrated highly
reproducible ‘type 2’ collision pattern (Fig. 3F).
The detailed profiles of these released lipids suggested sev-
eral general conclusions. First, monomeric CD1d proteins were
bound to phospholipids, sphingomyelin, type 1 hexosylceramide,
as well as other lipids that were not specifically identified (Fig.
3A). Second, TCR-CD1d complex formation largely or com-
pletely excluded CD1d bound to phosphatidylcholine (m/z 808.6
with the m/z 749.3 product), sphingomyelin (m/z 753.6 with m/z
694.4 product), phosphatidylethanolamine (m/z 738.5 with m/z
695.3 product), and the type 1 hexosylceramide with a monoun-
saturated lipid tail (m/z 722.6 with m/z 542.4 fragment). Third,
lipids eluted from the TCR-CD1d complexes contained type
2 monohexosylceramides ranging from C33-42 in chain length
(Fig. 3A). Further, the characteristic patterns of loss in CID
analyses by type 1 (18, 162, and 180 mu) and type 2 (162 mu)
hexosylceramides implicated a differing conformation of these
ceramide-based lipids. This interpretation is consistent with the
TCR discriminating structural classes of lipids including gly-
coslyceramides, and possiblyα- versus β-linked hexosylceramides.
The molar concentrations of hexosylceramides eluted from
the early and late complexes were determined using HPLC-MS in
comparison to standards, and this material tested for their ability
to elicit cytokine production froman iNKT cell hybridoma,DN32.
The late fraction did not have detectable activity, while the molar
activity observed in the early fraction was similar to that of a
synthetic antigen for iNKT cells known as α-galactosylceramide,
KRN7000 (Fig. 3G). Thus, our approach was successful as a TCR-
based affinity trap for selecting antigenic glycolipids that ligate
TCR to CD1d out of a complex mixture of natural lipids. The
equipotency of type 2 hexosylceramides andα-galactosylceramide
was consistent with the type 2 hexosylceramides being an α-linked
lipid. Although only trace amounts of the type 2 monohexosyl-
ceramide could be recovered from ternary complexes of CD1d-
lipid-TCR, 1D-proton nuclear magnetic resonance spectroscopy
(NMR) carried out on a 900MHz instrument identified a doublet
with a chemical shit of 4.85 ppm, consistent with the anomeric
proton resonance of α-monohexosylceramide (Fig. S1) (15).
Identification of ligands at high mass resolution. To further
biochemically characterize the lipids that promoted the formation
of TCR-lipid-CD1d complexes, we separately analyzed eluents
from milk lipid-treated protein monomers present in the late
fraction, untreated CD1d, and untreated TCR (Fig. 4). Here, we
took advantage of the higher mass accuracy of a quadrupole time-
of-flight (Q-ToF) mass detector coupled with chromatographic
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separation in normal-phase HPLC-MS to confirm the identity
of the key ions. Using this method, the major ions previously
identified by nanoelectrospray MS were confirmed and assigned
based on highmass accuracy andHPLC retention time, compared
with standards as phosphatidylcholine (38.1 min, m/z 786.601),
phosphatidylethanolamine (20.5 min, m/z 716.523), type 1 hex-
osylceramide (4.1 min, m/z 700.578), and type 2 hexosylceramide
(4.1 min, m/z 702.590, 716.604 and 786.682) (Figure 4). No sub-
stantial false positive signals were derived from lipids released
from the TCR, indicating that the lipids detected were carried
by CD1d. As seen with the nanospray method (Fig. 3), CD1d
alone andmixed CD1d and TCRmonomers bound phosphatidyl-
choline, phosphatidylethanolamine, and type 1 monohexosylce-
ramides (Fig. 4 and S2), but these were excluded from CD1d-
TCR complexes. Conversely, type 2 hexosylceramides eluted with
low or undetectable signals from milk lipid treated monomers,
but were highly enriched in CD1d-TCR complexes. Thus, CD1d
bound many lipids, but the iNKT TCRs selectively captured
CD1d bound to type 2 hexosylceramides (Fig. S3).
Structural identification of type 1 and 2 hexosylceramides.
Despite their strikingly-different patterns of bindingwithin, or be-
ing excluded from, CD1d-TCR complexes, normal-phase HPLC-
MS showed that type 1 and 2 hexosylceramides had equivalent
retention time and the same underlying molecular composition,
except for variations in lipid tail length and unsaturation. CID-
MS experiments using the ion trap architecture, however showed
different fragmentation patterns for type 1 and type 2 hexosyl-
ceramides (Fig. 3). We next asked whether anomeric variants
could be distinguished by CID-MS. First, we produced synthetic
standards differing only in the stereochemistry of their hexose at-
tachment. Both glucosyl and galactosyl variants were synthesized,
with dihydrosphingosine (d18:0) as their lipid backbones based on
the molecular composition of type 2 hexosylceramides identified
in the milk-derived early fraction. These synthetic standards had
a similar retention time by normal-phase HPLC to the early-
eluting milk lipids (Fig. S4). The synthetic standards were tested
for their ability to activate the DN32 iNKT cell hybridoma after
loading in CD1d-expressing RAW264.7 cells. For both glucosyl
and galactosyl synthetic standards, activity was observed for the
α-linked variants, but not for the β-linked variants (Fig. 5A).
Positive mode ion trap CID-MS of sodiated adducts of these
synthetic hexosylceramides was carried out under conditions that
matched those used for milk-derived compounds (Fig. 3), and
over a range of collision energy settings (Fig. 5B). Collision of
the α-glucosylceramide synthetic standard demonstrated almost
exclusively a primary loss of 162 mu, matching the pattern for
type 2 milk-derived hexosylceramides. In contrast, β-glucosyl
standards matched the fragmentation pattern seen for type 1
hexosylceramides from milk, showing a loss of 18 mu at a similar
frequency as loss of 162 mu. Although both patterns involved the
loss of 162 mu as a hexosyl unit, analysis over a range of collision
energy demonstrated that β-glucosylceramide also lost 18 mu
and 180 mu, whereas α-glucosylceramide showed neither of these
fragmentations at a substantial frequency. Parallel analyses of α-
and β-galactosylceramide standards showed similar characteristic
α- and β- collision patterns (Fig. S5). Matched synthetic α- and β-
glucosylceramide and galactosylceramide standards based on the
type 1 hexosylceramide lipid backbone structure showed similar
characteristic α- and β- collision patterns, demonstrating that the
anomeric linkage discrimination by this technique was not limited
to dihydrosphingosine-based glycosphingolipids (Fig. S6). Ion
trap CID-MS of α-galactosylceramide with a phytosphingosine
base also fragmented with the pattern matching type 2 hexosyl-
ceramides. We concluded from these experiments that linear ion
trap MS could sensitively distinguish α- from β-hexosylceramides
under the conditions measured for a range of lipids with differing
tail lengths and unsaturations.
We compared the collision patterns of the major hexosylce-
ramide ions from cow’s milk lipids. Unfractionated cow’s milk
glucosylceramides demonstrated a fragmentation pattern charac-
teristic of β-hexosylceramide standards (Fig. 5C), consistent with
the main lipid in the starting material being β-glucosylceramide.
The activity-enriched cow’s milk glucosylceramide showed a β-
hexosylceramide collision pattern, but with an increased fre-
quency of a type 2 pattern characterized by the loss of the
sugar headgroup (162 mu). The antigenic lipids captured in the
TCR trap assay showed the fragmentation pattern typical of α-
hexosylceramides.We concluded from these experiments that the
TCR trap captured type 2 α-linked hexosylceramides from cow’s
milk. To address the possibility that these type 2 hexosylceramides
were derived frommicrobes present in cow’s milk, we purified the
monohexosylceramide fraction from calf thymus, a mammalian
lipid source previously shown activate iNKT cells (15). Several
ions with the m/z seen in cow’s milk were also present in calf
thymus, including ions corresponding to type 2 hexosylceramides
m/z 724.7 and 808.8 (Fig. S7). Linear ion trap CID-MS of un-
treated calf thymus hexosylceramides showed a characteristic β-
hexosylceramide pattern. After activity enrichment of thymus
hexosylceramides by treatment with β-glucosidase and TLC frac-
tionation as in Fig. 1, we observed a collision pattern consistent
with the presence of α-hexosylceramides, based on a substantial
increase in the abundance of the ion representing a primary loss
of the sugar headgroup.
Discussion
Uncovering the specific antigens recognized by iNKT cells is cen-
tral to understanding their roles in health and disease. Although
lipid antigens for iNKT cells have been identified in the microbial
world (6-10), experimental evidence has demonstrated important
roles for endogenous and environmental lipid antigens. Several
candidate endogenous lipid antigens have been proposed (13,
14, 20-22), though technical limitations in the ability to detect
these antigens has hampered our ability to determine their con-
textual roles. Here, we provide direct biochemical evidence for α-
hexosylceramide derived from a mammalian source, cow’s milk.
There is increasing evidence that iNKT cells encounter lipid
antigens at mucosal surfaces. CD1-dependent immunomodula-
tory lipids have been identified in gut microbes (11, 12), pollen
(23), house dust (24), and in our work, cow’s milk. We have
previously demonstrated that cow’s milk contains substantially
more lipid antigen activity than human or mouse milk. Although
native triglycerides are removed from infant formula during pro-
cessing, bovine polar lipids, including lipid antigens for iNKT
cells, are retained in the final product (15). Studies in germ-free
mice suggest that the iNKT cell compartment can be shaped by
CD1d-lipid signals in the enteral tract (11, 25), and thus early-life
exposure to cow’smilk-based infant formulamight similarly shape
human mucosal iNKT cells in early life. In adult mice, orally-
delivered antigen activates iNKT cells in the gut (26), suggesting
that exposure to dietary lipid antigens in adult life may also
have consequences. Interestingly, it is unclear whether cows have
iNKT cells (27), as their CD1d does not present the long-chain
α-galactosylceramide commonly used as a tool in mice and hu-
mans (28). CD1d can present short-chain α-galactosylceramides
(28, 29), and it is possible that an increased presence of α-
hexosylceramdies in their milk and tissues could lead to thymic
deletion of iNKT cells, as has been observed in mice in the
presence of exogenous α-galactosylceramide (30).
Although the bulk solids in milk derive overwhelmingly from
mammary glands, we cannot formally rule out that coloniz-
ing microbes synthesized, or played a role in the synthesis of
the α-hexosylceramides present in cow’s milk. Several features
of our data argue against possible contamination of milk by
microbial products. We have previously observed iNKT cell-
545
546
547
548
549
550
551
552
553
554
555
556
557
558
559
560
561
562
563
564
565
566
567
568
569
570
571
572
573
574
575
576
577
578
579
580
581
582
583
584
585
586
587
588
589
590
591
592
593
594
595
596
597
598
599
600
601
602
603
604
605
606
607
608
609
610
611
612
Footline Author PNAS Issue Date Volume Issue Number 5
613
614
615
616
617
618
619
620
621
622
623
624
625
626
627
628
629
630
631
632
633
634
635
636
637
638
639
640
641
642
643
644
645
646
647
648
649
650
651
652
653
654
655
656
657
658
659
660
661
662
663
664
665
666
667
668
669
670
671
672
673
674
675
676
677
678
679
680
Submission PDF
stimulating activity in the monohexosylceramide fractions of
the milks, sera, and internal organs of multiple animal species
(14, 15). The N-acyl chain usage of the α-hexosylceramides
that we identified in this report mirror that of the bulk β-
glucosylceramides in cow’s milk, suggesting that these lipids are
of mammalian origin. We also identified type 2 hexosylceramides
from calf thymus with the same m/z as those in cow’s milk.
These thymic hexosylceramides, like those found in cow’s milk,
shifted from a β-hexosylceramide pattern toward a characteris-
tic α-hexosylceramide collision pattern after activity enrichment.
Currently, the level of α-hexosylceramide identified from cow’s
milk, a relatively abundant and potent natural source of lipid
antigen, is near the limit of detection for the TCR trap assay
system. However, we are continuing to improve the system so
that lipids can be captured and identified from smaller amounts
of source material.
The stereochemistry of organicmolecules can have significant
biological consequences. Determination of stereochemistry has
largely been accomplished by NMR. However, for rare com-
pounds such as endogenous iNKT cell lipid antigens, purification
of sufficientmaterial for complete, multi-dimensional NMRanal-
ysis is currently not possible. As shown in this report and others
(31, 32), CID-MS can also be used to determine stereochemical
features. We tested α- and β-linked synthetic standards with both
sphingosine and dihydrosphingosine bases, and found consistent
characteristic α- and β- fragmentation patterns, showing that this
detection method was not limited to certain lipid backbones.
Interestingly, these collision patterns were only observed with
selected positive mode adducts, including sodium and rubidium.
We hypothesize that for the β-hexosylceramide structure, positive
adducts with a sufficiently large valence, such as sodium and
rubidium, can coordinate elements on both sides of the glycoside
bond, stabilizing the glycoside bond during collision, thus reduc-
ing the propensity for cleavage of the sugar headgroup. For α-
hexosylceramide, this headgroup stabilization may be sterically
hindered, thus allowing for fragmentation across the glycoside
bond at a lower energy.
Identification of CD1d-presented lipid antigens has largely
relied on indirect evidence such as extrapolation from cells de-
ficient in lipid synthesis genes (22, 33), or fractionation of crude
lipid sources with activity tracking within these fractions (14,
20). These approaches have been useful, but do not directly
demonstrate recognition by the TCR, and rely on correlations
between two or more assays. Here, we used a direct method for
antigen discovery, the TCR trap assay. This approach that uses
ternary complex formation both as the preparative method to
recover lipids of interest and the key assay to demonstrate the
role of these lipids in ligating CD1d and TCR. The TCR trap
assay has also been used successfully to identify CD1a ligands
(17), and could be used to identify ligands for other CD1 isoforms,
or even MR1. This approach will allow tracking of rare lipids
from virtually any source, including from complex mixtures, or
limited starting materials, which represent common challenges
when starting with mammalian tissues and cells.
Methods and materials
Initial lipid activity enrichment was performed as previously
described (15). Mass spectrometry analyses were performed on
a Thermo-Fisher LXQ ion trap mass spectrometer or an Agilent
6520Accurate-MassQ-ToFwithHPLC. For details of experimen-
tal conditions and analysis, see SI Materials and Methods.
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